The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 60 | — | 20.1x | Near average | |
Growth | 7 | — | 5.6% | Below average | |
Quality | 62 | 9314.9% | 7.6% | Near average | |
Safety | 3 | 9.9x | 0.4x | Below average | |
Capital Return | 72 | — | 2.19% | Above average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Bright Minds Biosciences Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Bright Minds Biosciences Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
The average price target for DRUG has seen a slight decline of 2.94% over the past 30 days, dropping from 164.33 to 159.5 dollars, despite the number of covering analysts remaining constant. This adjustment reflects a more conservative short-term outlook, with a notable dispersion between the high target (220 dollars) and the low target (126 dollars), indicating uncertainty regarding fair valuation despite a consensus Buy recommendation.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.